News 2026.08.19

SBI Investment Portfolio Company MEPSGEN Selected for the Ministry of SMEs and Startups’ ‘Global TIPS’… Ramping Up Its DDS Business with Up to KRW 5 Billion in R&D Support

MEPSGEN, an SBI Investment portfolio company with microphysiological system (MPS) and drug delivery system (DDS) platforms, has been selected for the general track of the ‘2026 Global TIPS’ program run by the Ministry of SMEs and Startups, and will work to strengthen the global competitiveness of ‘NanoCalibur®,’ its automated nanoparticle production equipment.
With up to KRW 5 billion in government R&D funding over a maximum of four years, the company will develop a ‘microfluidics-based next-generation DDS production scale-up platform,’ with Professor Myerson's research team at MIT participating as a global technology validation partner to support performance validation and advise on process development.
Building on this selection, MEPSGEN plans to enhance the production scalability and versatility of the NanoCalibur platform, developing it into a next-generation DDS manufacturing platform for use by global pharmaceutical and biotech companies, and to accelerate its push into global markets.

The full article is available at the link below.